APA (7th ed.) Citation

Almeida-Santiago, C., Quevedo-Abeledo, J. C., Hernández-Hernández, V., de Vera-González, A., Gonzalez-Delgado, A., González-Gay, M. Á., & Ferraz-Amaro, I. (2022). Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis. Scientific Reports, 12(1), . https://doi.org/10.1038/s41598-022-18128-5

Chicago Style (17th ed.) Citation

Almeida-Santiago, Cristina, Juan Carlos Quevedo-Abeledo, Vanesa Hernández-Hernández, Antonia de Vera-González, Alejandra Gonzalez-Delgado, Miguel Ángel González-Gay, and Iván Ferraz-Amaro. "Interleukin 1 Receptor Antagonist Relation to Cardiovascular Disease Risk in Patients with Rheumatoid Arthritis." Scientific Reports 12, no. 1 (2022). https://doi.org/10.1038/s41598-022-18128-5.

MLA (9th ed.) Citation

Almeida-Santiago, Cristina, et al. "Interleukin 1 Receptor Antagonist Relation to Cardiovascular Disease Risk in Patients with Rheumatoid Arthritis." Scientific Reports, vol. 12, no. 1, 2022, https://doi.org/10.1038/s41598-022-18128-5.